BioCentury
ARTICLE | Company News

CHMP recommends label expansion for Menveo

March 16, 2012 11:54 PM UTC

EMA's CHMP issued a positive opinion on a proposed label expansion for Menveo meningitis vaccine from Novartis AG (NYSE:NVS; SIX:NOVN) to include children ages 2-11 years of age. The vaccine is alread...